Implication of snoRNA U50 in human breast cancer

Journal of Genetics and Genomics

Volumn 36, Issue 8, 2009, Pages 447-454

  Dong, Xue Yuan ^a   Guo, Peng ^a   Boyd, Jeff ^b   Sun, Xiaodong ^a   Li, Qunna ^a   Zhou, Wei ^a   Dong, Jin Tang ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b FOX CHASE CANCER CENTER   (United States)

Author keywords

breast cancer; snoRNA; tumor suppressor gene; U50

Indexed keywords

SMALL NUCLEOLAR RNA;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; COHORT ANALYSIS; CONTROLLED STUDY; DOWN REGULATION; GENE DELETION; GENE EXPRESSION; GENE FUNCTION; GENE MUTATION; GENOTYPE; HOMOZYGOSITY; HUMAN; POLYMERASE CHAIN REACTION; PRIMARY TUMOR; SOMATIC MUTATION; TUMOR GENE; TUMOR SUPPRESSOR GENE; U50 GENE;

ALLELES; BASE SEQUENCE; BREAST NEOPLASMS; CELLS, CULTURED; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOME, HUMAN; HUMANS; MUTATION; RISK FACTORS; RNA, SMALL NUCLEOLAR; TRANSCRIPTION, GENETIC;

EID: 68349143121     PISSN: 16738527     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1673-8527(08)60134-4     Document Type: Article

References (38)

1. Abdollahi A., Pisarcik D., Roberts D., Weinstein J., Cairns P., and Hamilton T.C. LOT1 (PLAGL1/ZAC1), the candidate tumor suppressor gene at chromosome 6q24-25, is epigenetically regulated in cancer. J. Biol. Chem. 278 (2003) 6041-6049
2. Basyuk E., Coulon V., Le Digarcher A., Coisy-Quivy M., Moles J.P., Gandarillas A., and Journot L. The candidate tumor suppressor gene ZAC is involved in keratinocyte differentiation and its expression is lost in basal cell carcinomas. Mol. Cancer Res. 3 (2005) 483-492
3. Callahan R., and Campbell G. Mutations in human breast cancer: An overview. J. Natl. Cancer Inst. 81 (1989) 1780-1786
4. Cesari R., Martin E.S., Calin G.A., Pentimalli F., Bichi R., McAdams H., Trapasso F., Drusco A., Shimizu M., Masciullo V., D'Andrilli G., Scambia G., Picchio M.C., Alder H., Godwin A.K., and Croce C.M. Parkin, a gene implicated in autosomal recessive juvenile parkinsonism, is a candidate tumor suppressor gene on chromosome 6q25-q27. Proc. Natl. Acad. Sci. USA 100 (2003) 5956-5961
5. Devilee P., van Vliet M., van Sloun P., Kuipers Dijkshoorn N., Hermans J., Pearson P.L., and Cornelisse C.J. Allelotype of human breast carcinoma: A second major site for loss of heterozygosity is on chromosome 6q. Oncogene 6 (1991) 1705-1711
6. Dong J.T. Chromosomal deletions and tumor suppressor genes in prostate cancer. Cancer Metastasis Rev. 20 (2001) 173-193
7. Dong J.T., Chen C., Stultz B.G., Isaacs J.T., and Frierson Jr. H.F. Deletion at 13q21 is associated with aggressive prostate cancers. Cancer Res. 60 (2000) 3880-3883
8. Dong X.Y., Chen C., Sun X., Guo P., Vessella R.L., Wang R.X., Chung L.W., Zhou W., and Dong J.T. FOXO1A is a candidate for the 13q14 tumor suppressor gene inhibiting androgen receptor signaling in prostate cancer. Cancer Res. 66 (2006) 6998-7006
9. Dong X.Y., Rodriguez C., Guo P., Sun X., Talbot J.T., Zhou W., Petros J., Li Q., Vessella R.L., Kibel A.S., Stevens V.L., Calle E.E., and Dong J.T. SnoRNA U50 is a candidate tumor-suppressor gene at 6q14.3 with a mutation associated with clinically significant prostate cancer. Hum. Mol. Genet. 17 (2008) 1031-1042
10. Dutrillaux B., Gerbault-Seureau M., and Zafrani B. Characterization of chromosomal anomalies in human breast cancer. A comparison of 30 paradiploid cases with few chromosome changes. Cancer Genet. Cytogenet. 49 (1990) 203-217
11. Foulkes W.D., Ragoussis J., Stamp G.W., Allan G.J., and Trowsdale J. Frequent loss of heterozygosity on chromosome 6 in human ovarian carcinoma. Br. J. Cancer 67 (1993) 551-559
12. Gold B., Kirchhoff T., Stefanov S., Lautenberger J., Viale A., Garber J., Friedman E., Narod S., Olshen A.B., Gregersen P., Kosarin K., Olsh A., Bergeron J., Ellis N.A., Klein R.J., Clark A.G., Norton L., Dean M., Boyd J., and Offit K. Genome-wide association study provides evidence for a breast cancer risk locus at 6q22.33. Proc. Natl. Acad. Sci. USA 105 (2008) 4340-4345
13. Han W., Han M.R., Kang J.J., Bae J.Y., Lee J.H., Bae Y.J., Lee J.E., Shin H.J., Hwang K.T., Hwang S.E., Kim S.W., and Noh D.Y. Genomic alterations identified by array comparative genomic hybridization as prognostic markers in tamoxifen-treated estrogen receptor-positive breast cancer. BMC Cancer 6 (2006) 92
14. Kishore S., and Stamm S. The snoRNA HBII-52 regulates alternative splicing of the serotonin receptor 2C. Science 311 (2006) 230-232
15. Knuutila S., Aalto Y., Autio K., Bjorkqvist A.M., El-Rifai W., Hemmer S., Huhta T., Kettunen E., Kiuru-Kuhlefelt S., Larramendy M.L., Lushnikova T., Monni O., Pere H., Tapper J., Tarkkanen M., Varis A., Wasenius V.M., Wolf M., and Zhu Y. DNA copy number losses in human neoplasms. Am. J. Pathol. 155 (1999) 683-694
16. Lee J.H., Kavanagh J.J., Wildrick D.M., Wharton J.T., and Blick M. Frequent loss of heterozygosity on chromosomes 6q, 11, and 17 in human ovarian carcinomas. Cancer Res. 50 (1990) 2724-2728
17. Li Y., Huang J., Zhao Y.L., He J., Wang W., Davies K.E., Nose V., and Xiao S. UTRN on chromosome 6q24 is mutated in multiple tumors. Oncogene 26 (2007) 6220-6228
18. Matera A.G., Terns R.M., and Terns M.P. Non-coding RNAs: Lessons from the small nuclear and small nucleolar RNAs. Nat. Rev. Mol. Cell Biol. 8 (2007) 209-220
19. Mattick J.S. RNA regulation: A new genetics?. Nat. Rev. Genet. 5 (2004) 316-323
20. Mattick J.S., and Makunin I.V. Small regulatory RNAs in mammals. Hum. Mol. Genet. 14 (2005) R121-R132
21. Mertens F., Johansson B., Hoglund M., and Mitelman F. Chromosomal imbalance maps of malignant solid tumors: A cytogenetic survey of 3185 neoplasms. Cancer Res. 57 (1997) 2765-2780
22. Morinaga N., Shitara Y., Yanagita Y., Koida T., Kimura M., Asao T., Kimijima I., Takenoshita S., Hirota T., Saya H., and Kuwano H. Molecular analysis of the h-warts/LATS1 gene in human breast cancer. Int. J. Oncol. 17 (2000) 1125-1129
23. Mourtada-Maarabouni M., Pickard M.R., Hedge V.L., Farzaneh F., and Williams G.T. GAS5, a non-protein-coding RNA, controls apoptosis and is downregulated in breast cancer. Oncogene 28 (2009) 195-208
24. Noviello C., Courjal F., and Theillet C. Loss of heterozygosity on the long arm of chromosome 6 in breast cancer: Possibly four regions of deletion. Clin. Cancer Res. 2 (1996) 1601-1606
25. Orphanos V., McGown G., Hey Y., Boyle J.M., and Santibanez- Koref M. Proximal 6q, a region showing allele loss in primary breast cancer. Br. J. Cancer 71 (1995) 290-293
26. Rodriguez C., Causse A., Ursule E., and Theillet C. At least five regions of imbalance on 6q in breast tumors, combining losses and gains. Genes Chromosomes Cancer 27 (2000) 76-84
27. Rosa-Rosa J.M., Pita G., Urioste M., Llort G., Brunet J., Lazaro C., Blanco I., Ramon Y.C.T., Diez O., de la Hoya M., Caldes T., Tejada M.I., Gonzalez-Neira A., and Benitez J. Genome- wide linkage scan reveals three putative breast-cancer-susceptibility loci. Am. J. Hum. Genet. 84 (2009) 115-122
28. Sandhu A.K., Kaur G.P., Reddy D.E., Rane N.S., and Athwal R.S. A gene on 6q 14-21 restores senescence to immortal ovarian tumor cells. Oncogene 12 (1996) 247-252
29. Schwendel A., Richard F., Langreck H., Kaufmann O., Lage H., Winzer K.J., Petersen I., and Dietel M. Chromosome alterations in breast carcinomas: Frequent involvement of DNA losses including chromosomes 4q and 21q. Br. J. Cancer 78 (1998) 806-811
30. Seute A., Sinn H.P., Schlenk R.F., Emig R., Wallwiener D., Grischke E.M., Hohaus S., Dohner H., Haas R., and Bentz M. Clinical relevance of genomic aberrations in homogeneously treated high-risk stage II/III breast cancer patients. Int. J. Cancer 93 (2001) 80-84
31. Sheng Z.M., Marchetti A., Buttitta F., Champeme M.H., Campani D., Bistocchi M., Lidereau R., and Callahan R. Multiple regions of chromosome 6q affected by loss of heterozygosity in primary human breast carcinomas. Br. J. Cancer 73 (1996) 144-147
32. Smith C.M., and Steitz J.A. Classification of gas5 as a multi-small-nucleolar-RNA (snoRNA) host gene and a member of the 5(-terminal oligopyrimidine gene family reveals common features of snoRNA host genes. Mol. Cell. Biol. 18 (1998) 6897-6909
33. Smith R.A., Cokkinides V., and Eyre H.J. Cancer screening in the United States, 2007: A review of current guidelines, practices, and prospects. CA. Cancer J. Clin. 57 (2007) 90-104
34. Sun X., Frierson H.F., Chen C., Li C., Ran Q., Otto K.B., Cantarel B.L., Vessella R.L., Gao A.C., Petros J., Miura Y., Simons J.W., and Dong J.T. Frequent somatic mutations of the transcription factor ATBF1 in human prostate cancer. Nat. Genet. 37 (2005) 407-412
35. Theile M., Seitz S., Arnold W., Jandrig B., Frege R., Schlag P.M., Haensch W., Guski H., Winzer K.J., Barrett J.C., and Scherneck S. A defined chromosome 6q fragment (at D6S310) harbors a putative tumor suppressor gene for breast cancer. Oncogene 13 (1996) 677-685
36. Varrault A., Ciani E., Apiou F., Bilanges B., Hoffmann A., Pantaloni C., Bockaert J., Spengler D., and Journot L. hZAC encodes a zinc finger protein with antiproliferative properties and maps to a chromosomal region frequently lost in cancer. Proc. Natl. Acad. Sci. USA 95 (1998) 8835-8840
37. Zeller C., Hinzmann B., Seitz S., Prokoph H., Burkhard-Goettges E., Fischer J., Jandrig B., Schwarz L.E., Rosenthal A., and Scherneck S. SASH1: A candidate tumor suppressor gene on chromosome 6q24.3 is downregulated in breast cancer. Oncogene 22 (2003) 2972-2983
38. Zhang Y., Matthiesen P., Siebert R., Harder S., Theile M., Scherneck S., and Schlegelberger B. Detection of 6q deletions in breast carcinoma cell lines by fluorescence in situ hybridization. Hum. Genet. 103 (1998) 727-729